Repeated surgical reduction of the mandible over a 19-year period due to fibrous dysplasia: A case report

Tomoko Sakata , Katsu Takahashi , Yangsun Kang , Honoka Kiso , Koichiro Irie , Hiroko Tsukamoto , Yasuaki Nakashima , Kazuhisa Bessho
{"title":"Repeated surgical reduction of the mandible over a 19-year period due to fibrous dysplasia: A case report","authors":"Tomoko Sakata ,&nbsp;Katsu Takahashi ,&nbsp;Yangsun Kang ,&nbsp;Honoka Kiso ,&nbsp;Koichiro Irie ,&nbsp;Hiroko Tsukamoto ,&nbsp;Yasuaki Nakashima ,&nbsp;Kazuhisa Bessho","doi":"10.1016/j.ajoms.2009.11.001","DOIUrl":null,"url":null,"abstract":"<div><p>Fibrous dysplasia is a benign bone lesion characterized by the replacement of normal tissue by fibro-osseous lesions with immature remodeling, which is now thought to be caused by GSα somatic mutation. The disease usually manifests early in life, and its growth is terminated in adulthood. Its malignant transformation is very rare. In the current report, a case of fibrous dysplasia of the mandible undergoing repeated surgery with a long-term follow-up duration is described. After the initial surgery performed at the age of 19 years, surgical reduction was performed eight times with an interval of 1–4 years over a 19-year course. At the age of 38 years, the lesion was still growing, while serum alkaline phosphatase remained within the normal range throughout the entire course. There was no evidence of malignancy on pathological examination. Immunohistochemistry using antibodies detecting bone morphogenetic proteins 2, 4, 6, and 7 (BMP-2, 4, 6, and 7) in order to assess bone growth activity showed positive staining for BMP-4 and 6, which are important markers of bone quality. Examining the expression of different BMP subtypes is useful for characterizing the bone-forming nature of fibrous dysplasia.</p></div>","PeriodicalId":100128,"journal":{"name":"Asian Journal of Oral and Maxillofacial Surgery","volume":"22 1","pages":"Pages 33-36"},"PeriodicalIF":0.0000,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ajoms.2009.11.001","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Oral and Maxillofacial Surgery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0915699210000105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Fibrous dysplasia is a benign bone lesion characterized by the replacement of normal tissue by fibro-osseous lesions with immature remodeling, which is now thought to be caused by GSα somatic mutation. The disease usually manifests early in life, and its growth is terminated in adulthood. Its malignant transformation is very rare. In the current report, a case of fibrous dysplasia of the mandible undergoing repeated surgery with a long-term follow-up duration is described. After the initial surgery performed at the age of 19 years, surgical reduction was performed eight times with an interval of 1–4 years over a 19-year course. At the age of 38 years, the lesion was still growing, while serum alkaline phosphatase remained within the normal range throughout the entire course. There was no evidence of malignancy on pathological examination. Immunohistochemistry using antibodies detecting bone morphogenetic proteins 2, 4, 6, and 7 (BMP-2, 4, 6, and 7) in order to assess bone growth activity showed positive staining for BMP-4 and 6, which are important markers of bone quality. Examining the expression of different BMP subtypes is useful for characterizing the bone-forming nature of fibrous dysplasia.

19年来因纤维发育不良反复手术复位下颌骨:1例报告
纤维发育不良是一种良性骨病变,其特征是正常组织被纤维骨性病变取代,并伴有不成熟的重塑,现在认为这是由gsa α体细胞突变引起的。这种疾病通常表现在生命早期,其生长在成年后终止。它的恶性转化是非常罕见的。在目前的报告中,一个病例的纤维结构不良的下颌骨接受反复手术与长期随访时间描述。在19岁进行首次手术后,在19年的疗程中进行了8次手术复位,间隔1-4年。在38岁时,病变仍在生长,而血清碱性磷酸酶在整个过程中保持在正常范围内。病理检查未见恶性肿瘤。使用抗体检测骨形态发生蛋白2、4、6和7 (BMP-2、4、6和7)来评估骨生长活性的免疫组织化学显示BMP-4和6呈阳性染色,这是骨质量的重要标志。检测不同BMP亚型的表达有助于表征纤维性发育不良的骨形成性质。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信